Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.
Jeni Larmour died after taking ketamine on her first night at Newcastle University back in September 2020. Sandra Larmour, Jeni’s mum, is now calling for the reclassification of the drug, claiming ...
US Weekly on MSN7d
What Celebrities and Doctors Have Said About Ketamine Use: Chrissy Teigen, Matthew Perry, MoreCelebrities like Chrissy Teigen and Matthew Perry have been open about using ketamine for their mental health – here's what ...
A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...
A now-former Iowa paramedic is facing charges after allegedly giving a man in need the wrong medication — and then failing to ...
Musk himself has said he uses the drug to treat depression, and he's frequently posted about it on X generally over the years ...
Recreational ketamine use has increased in the United States in recent years, outpacing its rise as a treatment for depression, a new analysis suggests. The hallucinogenic drug — a controlled ...
A recent study published in the journal Brain has revealed new insights into the neurological underpinnings of levodopa-induced dyskinesia, a common and debilitating complication of Parkinson’s ...
A fatal medication error and subsequent involuntary manslaughter charge highlights the ongoing challenges of error reporting in EMS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback